Bottom line
What is KMVAX's expense ratio?
KMVAX's expense ratio is 1.35%, or about $135 a year on every $10,000 invested. That is more expensive than 85% of large value funds we track (median 0.81%). Its expense ratio includes a 0.07% 12b-1 marketing fee.
Updated Jan 28, 2026
KMVAX fee table
| Net expense ratio | 1.35% |
|---|---|
| Gross expense ratio | 1.3% |
| Management fee | 0.9% |
| 12b-1 (distribution) fee | 0.07% |
| Other expenses | 0.33% |
| Fee waiver / reimbursement | 0.05% |
| Redemption fee | -1% |
Source: Fund prospectus fee table, filed Jan 28, 2026
What KMVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| KMVAX | $137 | $422 | $723 | $1,577 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.35% expense ratio costs roughly $72,500 in lost growth, versus about $45,600 for the median large value fund (0.81%).